Potential in vivo transfer of a bla

Aged, 80 and over Bacterial Proteins / genetics Escherichia coli / genetics Escherichia coli Infections / microbiology Female Gene Transfer, Horizontal Humans Klebsiella Infections / microbiology Klebsiella pneumoniae / genetics Plasmids / genetics Sequence Analysis, DNA beta-Lactamases / genetics
E coli ESBL Extended-spectrum beta-lactamases Horizontal transfer IncFII plasmid K. pneumoniae Nanopore sequencing ST23

Journal

Journal of microbiological methods
ISSN: 1872-8359
Titre abrégé: J Microbiol Methods
Pays: Netherlands
ID NLM: 8306883

Informations de publication

Date de publication:
04 2019
Historique:
received: 28 09 2018
revised: 28 01 2019
accepted: 05 02 2019
pubmed: 11 2 2019
medline: 12 6 2020
entrez: 11 2 2019
Statut: ppublish

Résumé

Horizontal transfer of plasmid-mediated antibiotic resistance has rarely been documented in vivo. Utilizing long-read (Oxford Nanopore) and short-read (Illumina) sequencing, we confirmed that a gut-colonizing Escherichia coli and a hypervirulent Klebsiella pneumoniae ST23, isolated from a surgical site culture of a patient receiving cefuroxime therapy, harboured a 100% identical bla

Identifiants

DOI: 10.1016/j.mimet.2019.02.004 PMID: 30738818
pubmed: 30738818
pii: S0167-7012(18)30789-9
doi: 10.1016/j.mimet.2019.02.004
pii:
doi:

Substances chimiques

Bacterial Proteins 0
beta-Lactamases EC 3.5.2.6

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-4

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Basil Britto Xavier (BB)

Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, Universiteit Antwerpen, Antwerp, Belgium.

Gesuele Renzi (G)

Clinical Microbiology Laboratory, University of Geneva Hospitals, Faculty of Medicine, Geneva, Switzerland.

Christine Lammens (C)

Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, Universiteit Antwerpen, Antwerp, Belgium.

Abdessalam Cherkaoui (A)

Clinical Microbiology Laboratory, University of Geneva Hospitals, Faculty of Medicine, Geneva, Switzerland.

Herman Goossens (H)

Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, Universiteit Antwerpen, Antwerp, Belgium.

Jacques Schrenzel (J)

Clinical Microbiology Laboratory, University of Geneva Hospitals, Faculty of Medicine, Geneva, Switzerland.

Stephan Harbarth (S)

Infection Control Program, University of Geneva Hospitals, Faculty of Medicine, Geneva, Switzerland.

Surbhi Malhotra-Kumar (S)

Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, Universiteit Antwerpen, Antwerp, Belgium. Electronic address: surbhi.malhotra@uantwerpen.be.

Articles similaires

Comprehensive comparative analysis and development of molecular markers for Lasianthus species based on complete chloroplast genome sequences.

Yue Zhang, Meifang Song, Deying Tang et al.
1.00
Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Sujet âgé de 80 ans ou plus › Potential in vivo transfer of a bla
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines bactériennes › Potential in vivo transfer of a bla
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Enterobacteriaceae › Escherichia › Escherichia coli › Potential in vivo transfer of a bla
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Enterobacteriaceae › Infections à Escherichia coli › Potential in vivo transfer of a bla
questionsmedicales.fr › Phénomènes génétiques › Recombinaison génétique › Transfert horizontal de gène › Potential in vivo transfer of a bla
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Potential in vivo transfer of a bla
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Enterobacteriaceae › Infections à Klebsiella › Potential in vivo transfer of a bla
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Enterobacteriaceae › Klebsiella › Klebsiella pneumoniae › Potential in vivo transfer of a bla
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Plasmides › Potential in vivo transfer of a bla
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Analyse de séquence d'ADN › Potential in vivo transfer of a bla
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Hydrolases › Amidohydrolases › bêta-Lactamases › Potential in vivo transfer of a bla